Power of computed-tomography-defined sarcopenia for prediction of morbidity after pancreaticoduodenectomy

BMC Medical Imaging

Table 2 Univariate analysis of risk factors for complications and fistulas after pancreaticoduodenectomy

	Complication < IIIb	Complication IIIb ≤	p<	No Grade B or C fistula	Grade B or C fistula	p<
CT data
A_VAT [cm²]	123	157	0.06	120	180.1	0.01
A_MPSO [cm²]	20.3	18.9	0.12	20.3	18.5	0.24
A_MSPI [cm²]	55.8	52.7	0.37	56.2	52.0	0.05
A_MVEN [cm²]	55.7	58.3	0.73	56.5	57.2	0.64
A_MTOT [cm²]	130	130.0	0.83	131	127	0.32
MA [HU]	40.7	33.0	0.01	40.3	33.1	0.01
SMI [cm²/m²]	44.5	44.9	0.77	44.9	43.4	0.30
DPP [mm]	17.3	19.3	0.14	17.5	18.7	0.55
DPD [mm]	3.00	2.40	0.04	3.00	2.00	0.01
Sarcopenic	9	28	0.04	4	22	0.01

Continuous parameters are reported as median, and categorical parameters are counted. DPP: Diameterof Pancreatic Parenchyma, DPD: Diameter of Pancreatic Duct; A_VAT: Area of visceral adipose tissue; A_MPSO: Area of psoas muscle; A_MSPI: Area of dorsospinal muscles; A_MVEN: Area of ventral abdominal muscles, A_MTOT: total muscle area. p: level of significance was determined by the Mann-Whitney-U Test. bold numbers indicate p < 0.05

ISSN: 1471-2342